{"gene":"GRK4","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1996,"finding":"GRK4 is a functional protein kinase capable of phosphorylating agonist-occupied purified β2-adrenergic receptor in vitro, augmenting desensitization of the rat LH/CG receptor upon coexpression in HEK293 cells, and all four splice variants incorporate [3H]palmitate (palmitoylation).","method":"In vitro phosphorylation assay with purified β2-adrenergic receptor; coexpression desensitization assay in HEK293 cells; [3H]palmitate metabolic labeling","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay plus functional cell-based desensitization, foundational paper with 160 citations","pmids":["8626439"],"is_preprint":false},{"year":1997,"finding":"GRK4α, but not the β, γ, or δ isoforms, phosphorylates rhodopsin in an agonist-dependent manner; GRK4α kinase activity is inhibited by Ca²⁺/calmodulin (IC50 ~80 nM) through direct interaction, while the other isoforms do not interact with calmodulin. GRK4 protein localizes to acrosomal and outer mitochondrial membranes of human spermatozoa, with GRK4γ being the only detectable isoform in sperm.","method":"Rhodopsin phosphorylation assay; CaM-Sepharose pulldown; immunochemistry and ultrastructural (EM) localization in sperm","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay with isoform-specific comparisons plus direct binding pulldown and subcellular localization by EM","pmids":["9092566"],"is_preprint":false},{"year":1998,"finding":"Rat GRK4A and GRK4B are both functional protein kinases demonstrated by rhodopsin phosphorylation; GRK4A mRNA is enriched in testicular spermatocytes/spermatids whereas GRK4B is enriched ~20-fold in renal outer medulla, indicating isoform-specific tissue distribution with distinct physiological functions.","method":"Rhodopsin phosphorylation assay; in situ hybridization; quantitative RT-PCR","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay combined with two independent localization methods","pmids":["9607785"],"is_preprint":false},{"year":1998,"finding":"GRK4δ facilitates sequestration of muscarinic m2 (and to a lesser extent m4) receptors in BHK-21 cells but not in COS-7 cells, indicating cell-type-dependent modulation of muscarinic receptor internalization.","method":"Receptor sequestration assay (loss of [3H]NMS surface binding) with GRK4δ coexpression in COS-7 and BHK-21 cells","journal":"The Journal of pharmacology and experimental therapeutics","confidence":"Medium","confidence_rationale":"Tier 3 — single coexpression assay, moderate mechanistic follow-up","pmids":["9495886"],"is_preprint":false},{"year":2000,"finding":"GRK4 mediates homologous desensitization of the metabotropic glutamate receptor mGlu1 in cerebellar Purkinje cells: GRK4 coexpression in HEK293 cells caused agonist-dependent mGlu1 desensitization, agonist stimulation induced GRK4 redistribution and colocalization with internalized receptor, kinase activity was required, and agonist-dependent phosphorylation of mGlu1 was demonstrated. Antisense reduction of GRK4 in Purkinje cells impaired mGlu1 desensitization.","method":"Coexpression desensitization assay in HEK293; receptor phosphorylation assay; confocal colocalization; antisense knockdown in cultured Purkinje cells","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (phosphorylation, localization, antisense KD) in both heterologous and native cells, 115 citations","pmids":["11099476"],"is_preprint":false},{"year":2003,"finding":"GRK4 mediates agonist-promoted desensitization of the heterodimeric GABA(B) receptor in cerebellar granule cells through a phosphorylation-independent mechanism: GRK4 kinase-domain deletion mutants still promoted desensitization, siRNA knockdown of GRK4 in granule cells blocked desensitization, and GRK4 transfection into HEK293 cells reconstituted desensitization without detectable ligand-induced receptor phosphorylation.","method":"siRNA knockdown in cerebellar granule cells; kinase-dead/deletion mutant transfection; electrophysiological desensitization assay in HEK293 cells","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 — loss-of-function siRNA plus domain-deletion mutagenesis with defined phenotypic readout, 100 citations","pmids":["12881416"],"is_preprint":false},{"year":2004,"finding":"Unlike GRK2, the N-terminal RGS-like domain of GRK4 does not interact with Gαq either in vitro or in cells and cannot inhibit Gαq-dependent signaling, establishing that GRK4 lacks functional Gαq interaction.","method":"In vitro Gαq binding assay; cell-based signaling assay comparing GRK2 and GRK4 N-terminal domains","journal":"Methods in enzymology","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding assay in vitro and in cells, but single lab","pmids":["15488187"],"is_preprint":false},{"year":2007,"finding":"GRK4 desensitizes GABA(B) receptor by forming a direct protein complex with the GB2 subunit: agonist stimulation translocated cytosolic GRK4 to the plasma membrane, and FRET analysis (GRK4-Cerulean/GB2R-Venus) plus co-immunoprecipitation confirmed a physical GRK4–GB2R complex. GRK5 also formed this complex but GRK2, GRK3, and GRK6 did not.","method":"FRET (fluorescent fusion proteins); co-immunoprecipitation; live-cell translocation imaging in BHK cells; Xenopus oocyte electrophysiology","journal":"Journal of cellular physiology","confidence":"High","confidence_rationale":"Tier 1–2 — FRET plus co-IP plus functional electrophysiology, orthogonal methods in single study","pmids":["17013811"],"is_preprint":false},{"year":2009,"finding":"GRK4 (specifically GRK4γ and GRK4α isoforms) directly interacts with and phosphorylates the agonist-activated dopamine D3 receptor: bimolecular fluorescence complementation showed agonist-dependent GRK4–D3R interaction at the membrane and intracellularly; GRK4γ and α isoforms caused 3- and 2-fold increases in D3R phosphorylation, respectively; GRK4 knockdown abolished D3R-mediated p44/42 phosphorylation and mitogenesis.","method":"Bimolecular fluorescence complementation (BiFC); co-immunoprecipitation; receptor phosphorylation assay; RNAi knockdown with signaling readout in human proximal tubule cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (BiFC, co-IP, phosphorylation, KD) with defined functional readout","pmids":["19520868"],"is_preprint":false},{"year":2013,"finding":"GRK4γ directly interacts with angiotensin II type 1 receptor (AT1R); the gain-of-function variant GRK4γ 142V increases AT1R protein expression via NF-κB-mediated transcriptional upregulation, decreases AT1R phosphorylation (reducing degradation), and augments AT1R-mediated calcium signaling. The interaction between GRK4γ and AT1R is decreased by the 142V variant.","method":"Co-immunoprecipitation; NF-κB luciferase reporter; chromatin immunoprecipitation; calcium imaging; GRK4γ 142V transgenic mice with aortic vasoconstriction assay","journal":"Hypertension","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods in cells plus in vivo transgenic confirmation","pmids":["24218433"],"is_preprint":false},{"year":2013,"finding":"c-Myc transcription factor binds to the GRK4 promoter and positively regulates GRK4 expression in human renal proximal tubule cells; angiotensin II (via AT1R) activates c-Myc phosphorylation, which in turn increases GRK4 expression and causes dopamine D1 receptor uncoupling from adenylyl cyclase.","method":"Chromatin immunoprecipitation; c-Myc inhibitor (10074-G5); AT1R blockade with losartan; adenylyl cyclase coupling assay","journal":"Hypertension","confidence":"High","confidence_rationale":"Tier 2 — ChIP plus pharmacological inhibition at multiple nodes, defining the Ang II→AT1R→c-Myc→GRK4→D1R axis","pmids":["23509080"],"is_preprint":false},{"year":2015,"finding":"FMRP (fragile X mental retardation protein) binds directly to a structured domain (G4RIF) in GRK4 mRNA via its C-terminal region, repressing GRK4 translation in cerebellar Purkinje cells; in Fmr1-null cerebellum, GRK4 protein is increased without change in mRNA, indicating translational repression by FMRP.","method":"In vitro FMRP–mRNA binding assay; RNA secondary structure analysis; Western blot and qRT-PCR in Fmr1-null cerebellum; reporter translational repression assay","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro binding plus structural characterization plus in vivo genetic model with translational readout","pmids":["26250109"],"is_preprint":false},{"year":2015,"finding":"GRK4 subfamily members (GRK5 and GRK6, but not GRK2/3) phosphorylate inactive (non-agonist-occupied) GPCRs including β2-adrenergic and M2 muscarinic receptors; this agonist-independent phosphorylation enhances arrestin recruitment to inactive receptors, and arrestin-3 discriminates between GRK2- and GRK5-mediated phosphorylation patterns.","method":"In vitro phosphorylation assay with inactive receptors; arrestin recruitment assay; constitutive activity controls; membrane association controls","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with rigorous controls distinguishing GRK subfamilies","pmids":["25770216"],"is_preprint":false},{"year":2020,"finding":"GRK4 directly interacts with and hyperphosphorylates the adiponectin receptor-1 (AdipoR1) in renal proximal tubule cells from spontaneously hypertensive rats (SHRs), uncoupling AdipoR1 from Gαi and impairing adiponectin-mediated inhibition of Na⁺-K⁺-ATPase; GRK4γ 142V transgenic mice replicate this phenotype, and siRNA-mediated GRK4 knockdown in vivo restores adiponectin-induced natriuresis and reduces blood pressure.","method":"Co-immunoprecipitation; point mutation abolishing receptor phosphorylation; GRK4γ 142V transgenic mice; renal siRNA knockdown via ultrasound-targeted microbubble destruction; Na⁺-K⁺-ATPase activity assay","journal":"Clinical science","confidence":"High","confidence_rationale":"Tier 2 — co-IP, mutagenesis rescue, transgenic and knockdown in vivo with defined physiological readout","pmids":["32940654"],"is_preprint":false},{"year":2020,"finding":"GRK4 co-localizes and co-immunoprecipitates with the endothelin ETB receptor in renal proximal tubule cells; in SHRs and GRK4γ 142V transgenic mice, ETBR is hyperphosphorylated by GRK4, impairing ETBR-mediated natriuresis and diuresis; siRNA knockdown or in vivo GRK4 reduction restores ETBR function.","method":"Co-immunoprecipitation; confocal colocalization; GRK4γ 142V transgenic mice; siRNA knockdown via ultrasound-targeted microbubble destruction; in vivo natriuresis assay","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 — co-IP plus transgenic and knockdown in vivo with functional natriuresis readout","pmids":["32687659"],"is_preprint":false},{"year":2023,"finding":"GRK4 phosphorylates the cholecystokinin B receptor (CCKBR/gastrin receptor) in renal proximal tubule cells; GRK4 and CCKBR co-localize and co-immunoprecipitate; GRK4 siRNA reduces CCKBR phosphorylation and restores gastrin-mediated inhibition of Na⁺-K⁺-ATPase activity in SHR cells.","method":"Co-immunoprecipitation; confocal co-localization; siRNA knockdown; Na⁺-K⁺-ATPase activity assay; GRK4 A142V transgenic mice","journal":"Clinical and experimental hypertension","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP plus functional enzyme assay and KD, single lab","pmids":["37641972"],"is_preprint":false},{"year":2023,"finding":"GRK4-mediated phosphorylation of dopamine D1R in skeletal muscle is regulated upstream by a ROS/c-Myc pathway: in insulin-resistant/T2DM mice, increased ROS elevates c-Myc expression, which transcriptionally upregulates GRK4, leading to D1R hyperphosphorylation and impaired insulin sensitivity; exercise reverses this axis, and GRK4 transgenic mice show worsened D1R phosphorylation and insulin resistance while AAV9-shGRK4 mice are more insulin sensitive.","method":"GRK4 transgenic and AAV9-shGRK4 mice; glucose and insulin tolerance tests; D1R phosphorylation assay; c-Myc ChIP; ROS measurement","journal":"Clinical science","confidence":"High","confidence_rationale":"Tier 2 — gain- and loss-of-function in vivo with defined molecular and physiological readouts","pmids":["37622333"],"is_preprint":false},{"year":2025,"finding":"GRK4 promotes arrhythmia after myocardial infarction by binding to and phosphorylating the M3 muscarinic acetylcholine receptor (M3-mAChR), which impedes M3-mAChR–Cx43 association, causing Cx43 downregulation and redistribution; GRK4 mRNA/protein stability is increased via METTL3-mediated m6A modification read by YTHDF1. GRK4 knockdown reduces Cx43 dysregulation and ventricular arrhythmia susceptibility.","method":"siRNA and adenoviral overexpression of GRK4 in cardiomyocytes; co-immunoprecipitation (GRK4–M3-mAChR; M3-mAChR–Cx43); m6A RNA methylation assay; METTL3/YTHDF1 interaction; in vivo arrhythmia susceptibility assay post-MI","journal":"Biochemical pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP plus KD/OE with defined arrhythmia and molecular readouts, single lab","pmids":["40484036"],"is_preprint":false},{"year":2025,"finding":"GRK4 R65L variant causes salt-sensitive hypertension via phosphorylation of triosephosphate isomerase 1 (TPI1), which promotes TPI1 nuclear translocation, reduces DHAP levels, increases H3K27ac binding to the Hao2 promoter, and upregulates Hao2-mediated renal oxidative stress. Immunoprecipitation-mass spectrometry identified increased GRK4–TPI1 interaction in kidneys of high-salt-fed GRK4 R65L mice.","method":"GRK4 R65L global and renal-targeted transgenic mice; immunoprecipitation–mass spectrometry; TPI1 phosphorylation and nuclear fractionation; H3K27ac ChIP; Hao2 AAV9 knockdown; oxidative stress measurement; pressure-natriuresis assay","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 — IP-MS identification plus multiple in vivo genetic manipulations, single lab, 0 citations (very recent)","pmids":["41407053"],"is_preprint":false},{"year":2025,"finding":"PM2.5 upregulates renal GRK4 expression via promoter hypomethylation; elevated GRK4 then phosphorylates and interacts with Nedd4L (a ubiquitin ligase), stabilizing Nedd4L phosphorylation; phospho-Nedd4L reduces ENaC ubiquitination, causing ENaC accumulation and sodium retention that drives hypertension. GRK4 overexpression exacerbated and knockdown attenuated these effects.","method":"Co-immunoprecipitation (GRK4–Nedd4L); methylation assay; lentiviral GRK4 overexpression/knockdown; ENaC ubiquitination assay; Western blot; in vivo blood pressure measurement","journal":"Blood pressure","confidence":"Medium","confidence_rationale":"Tier 2 — co-IP plus lentiviral gain/loss-of-function with defined sodium channel readout, single lab, very recent","pmids":["41351606"],"is_preprint":false}],"current_model":"GRK4 is a palmitoylated, constitutively active serine/threonine kinase (expressed highly in testis and renal proximal tubule) that phosphorylates and desensitizes multiple GPCRs—including dopamine D1R, D3R, mGlu1, LH/CG receptor, ETBR, CCKBR, and M3-mAChR—as well as non-GPCR substrates such as adiponectin receptor-1 and TPI1, with its activity regulated by isoform-specific calmodulin inhibition and transcriptionally controlled by the Ang II→AT1R→c-Myc axis; gain-of-function variants (R65L, A142V, A486V) cause constitutive receptor hyperphosphorylation that impairs renal natriuresis and elevates blood pressure, while in the cerebellum FMRP restrains GRK4 translation to control GABA(B) receptor desensitization."},"narrative":{"teleology":[{"year":1996,"claim":"Establishing GRK4 as a functional GPCR kinase resolved whether this testis-enriched gene encodes an active enzyme: all four splice variants phosphorylated agonist-occupied β2-adrenergic receptor, desensitized LH/CG receptor, and incorporated palmitate, placing GRK4 in the GRK family with a membrane-anchoring mechanism.","evidence":"In vitro kinase assay with purified β2AR; HEK293 coexpression desensitization; [³H]palmitate labeling","pmids":["8626439"],"confidence":"High","gaps":["Endogenous substrates in testis not identified","Palmitoylation site(s) not mapped","Contribution to spermatogenesis unknown"]},{"year":1997,"claim":"Demonstrating that Ca²⁺/calmodulin selectively inhibits GRK4α (IC₅₀ ~80 nM) but not the other isoforms revealed an isoform-specific regulatory mechanism, while EM localization to sperm acrosomes and mitochondria defined the first subcellular address for endogenous GRK4.","evidence":"Rhodopsin phosphorylation with CaM titration; CaM-Sepharose pulldown; immunoEM of human spermatozoa","pmids":["9092566"],"confidence":"High","gaps":["Calmodulin-binding site on GRK4α not mapped","Functional consequence of CaM regulation in spermatozoa not tested"]},{"year":2000,"claim":"Identifying mGlu1 as an endogenous GRK4 substrate in cerebellar Purkinje cells established GRK4 as a physiologically relevant kinase outside of testis, with antisense knockdown confirming a non-redundant role in mGlu1 desensitization.","evidence":"HEK293 desensitization/phosphorylation assays; confocal colocalization; antisense oligonucleotide knockdown in cultured Purkinje cells","pmids":["11099476"],"confidence":"High","gaps":["Phosphorylation sites on mGlu1 not mapped","In vivo cerebellar phenotype of GRK4 loss not examined"]},{"year":2003,"claim":"Showing that GRK4 desensitizes GABA(B) receptor through a phosphorylation-independent mechanism expanded the paradigm beyond kinase activity, indicating GRK4 can function as a scaffolding partner for receptor regulation.","evidence":"Kinase-dead/deletion mutants retain desensitization; siRNA knockdown in cerebellar granule cells; HEK293 electrophysiology","pmids":["12881416"],"confidence":"High","gaps":["Molecular basis of phosphorylation-independent desensitization (e.g., arrestin recruitment) not defined","Which GRK4 domain mediates the scaffolding function unknown"]},{"year":2007,"claim":"FRET and co-IP identification of a direct GRK4–GB2 subunit complex provided the physical basis for GABA(B) receptor desensitization and showed specificity within the GRK family (GRK2/3/6 did not form this complex).","evidence":"FRET (Cerulean/Venus fusions); co-immunoprecipitation; translocation imaging in BHK cells; Xenopus oocyte electrophysiology","pmids":["17013811"],"confidence":"High","gaps":["GB2 binding interface on GRK4 not mapped","Whether GB2 interaction is phosphorylation-dependent or -independent not resolved"]},{"year":2009,"claim":"Demonstrating that GRK4γ and GRK4α phosphorylate dopamine D3R in renal proximal tubule cells, with knockdown abolishing D3R-mediated ERK signaling, linked GRK4 to renal dopaminergic signaling and natriuretic regulation.","evidence":"BiFC; co-IP; receptor phosphorylation assay; RNAi in human renal proximal tubule cells","pmids":["19520868"],"confidence":"High","gaps":["D3R phosphorylation sites by GRK4 not mapped","In vivo renal D3R desensitization phenotype not tested"]},{"year":2013,"claim":"Two parallel studies revealed that GRK4 expression is transcriptionally controlled by angiotensin II→AT1R→c-Myc signaling, and that the gain-of-function GRK4γ 142V variant reciprocally upregulates AT1R via NF-κB, establishing a positive feedback loop in hypertension pathogenesis.","evidence":"ChIP for c-Myc on GRK4 promoter; c-Myc inhibitor; losartan; NF-κB reporter; GRK4γ 142V transgenic mice with vasoconstriction and calcium assays","pmids":["23509080","24218433"],"confidence":"High","gaps":["Relative contribution of c-Myc versus other transcription factors not quantified","Whether AT1R upregulation by 142V occurs in human kidneys not confirmed"]},{"year":2015,"claim":"Discovery that FMRP directly binds a G4RIF structural element in GRK4 mRNA and represses its translation connected GRK4 to fragile X syndrome biology and explained elevated GRK4 protein in Fmr1-null cerebellum.","evidence":"In vitro FMRP–RNA binding; RNA structure analysis; Fmr1-KO mouse cerebellum Western/qRT-PCR; reporter translation assay","pmids":["26250109"],"confidence":"High","gaps":["Whether elevated GRK4 protein causes specific GABA(B) or mGlu1 dysfunction in Fmr1-KO not tested","Other translational regulators of GRK4 not examined"]},{"year":2020,"claim":"Extending GRK4 substrates beyond GPCRs, two studies showed that GRK4 hyperphosphorylates adiponectin receptor-1 and endothelin ETB receptor in hypertensive rat kidneys, with in vivo GRK4 siRNA restoring natriuresis and lowering blood pressure, establishing GRK4 as a master desensitizer of multiple renal antinatriuretic pathways.","evidence":"Co-IP; GRK4γ 142V transgenic mice; renal-targeted siRNA via ultrasound microbubble destruction; Na⁺-K⁺-ATPase activity; natriuresis assays","pmids":["32940654","32687659"],"confidence":"High","gaps":["Phosphorylation sites on AdipoR1 and ETBR not mapped","Whether GRK4 simultaneously targets all these receptors in the same cell not determined"]},{"year":2023,"claim":"Identification of CCKBR as another GRK4 renal substrate and demonstration that a ROS/c-Myc/GRK4 axis impairs D1R-mediated insulin sensitivity in skeletal muscle broadened GRK4 function to metabolic regulation beyond kidney.","evidence":"Co-IP (GRK4–CCKBR); GRK4 transgenic and AAV9-shGRK4 mice; glucose/insulin tolerance tests; c-Myc ChIP in skeletal muscle","pmids":["37641972","37622333"],"confidence":"High","gaps":["Whether GRK4 directly phosphorylates CCKBR intracellular domains not confirmed with site mutagenesis","Skeletal muscle-specific GRK4 knockout not performed"]},{"year":2025,"claim":"Three recent studies expanded the GRK4 substrate repertoire to non-receptor targets: GRK4 phosphorylates TPI1 (promoting its nuclear translocation and epigenetic upregulation of Hao2 in salt-sensitive hypertension), binds M3-mAChR to disrupt Cx43-mediated gap junctions and promote post-MI arrhythmia (with GRK4 stability itself controlled by METTL3/m⁶A/YTHDF1), and phosphorylates Nedd4L to stabilize ENaC and cause sodium retention under PM2.5 exposure.","evidence":"IP-MS (GRK4–TPI1); GRK4 R65L transgenic mice; H3K27ac ChIP; co-IP (GRK4–M3-mAChR, GRK4–Nedd4L); m⁶A-RIP; in vivo arrhythmia and blood pressure assays","pmids":["41407053","40484036","41351606"],"confidence":"Medium","gaps":["TPI1 phosphorylation site(s) and direct kinase assay not reported","M3-mAChR and Nedd4L findings each from a single lab, awaiting independent replication","Structural basis for GRK4 recognition of non-GPCR substrates entirely unknown"]},{"year":null,"claim":"Key unresolved questions include: the structural basis for GRK4's broad substrate promiscuity across GPCRs and non-GPCR targets, the phosphorylation-independent desensitization mechanism for GABA(B) receptor, identification of phosphorylation sites on most reported substrates, and whether a GRK4 knockout mouse recapitulates the predicted hypotensive/salt-resistant phenotype.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal structure of GRK4 or GRK4–substrate complex","Full GRK4 knockout mouse phenotype not reported in the literature","Phosphorylation sites mapped on very few substrates"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,1,4,8,13,14,15,18]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5,7]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,7,8,9]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[7]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[1]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,4,5,8,9,10,13,14,15,16]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[13,14,19]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[4,5,7,11]}],"complexes":[],"partners":["DRD1","DRD3","GRM1","GABBR2","ADIPOR1","EDNRB","AGTR1","TPI1"],"other_free_text":[]},"mechanistic_narrative":"GRK4 is a palmitoylated serine/threonine kinase of the GRK4 subfamily that phosphorylates and desensitizes a broad repertoire of G protein-coupled receptors—including dopamine D1R and D3R, mGlu1, GABA(B), LH/CG, ETB, CCKB, and M3-mAChR—as well as non-GPCR substrates such as adiponectin receptor-1, TPI1, and Nedd4L, thereby governing renal sodium handling, vascular tone, insulin sensitivity, and cardiac gap-junction integrity [PMID:8626439, PMID:11099476, PMID:19520868, PMID:32940654, PMID:41407053, PMID:40484036]. The kinase exists as four splice isoforms whose activity is differentially regulated by Ca²⁺/calmodulin (which inhibits GRK4α but not β/γ/δ) and whose expression is transcriptionally driven by an angiotensin II→AT1R→c-Myc axis, while post-transcriptionally FMRP represses GRK4 translation in cerebellum and METTL3-mediated m⁶A modification stabilizes GRK4 mRNA in cardiomyocytes [PMID:9092566, PMID:23509080, PMID:26250109, PMID:40484036]. Gain-of-function variants (R65L, A142V, A486V) confer constitutive receptor hyperphosphorylation in renal proximal tubule cells, impairing natriuresis and causing salt-sensitive hypertension in transgenic models [PMID:24218433, PMID:32687659, PMID:41407053]. GRK4 can also desensitize GABA(B) receptors through a phosphorylation-independent mechanism that involves direct binding to the GB2 subunit [PMID:12881416, PMID:17013811]."},"prefetch_data":{"uniprot":{"accession":"P32298","full_name":"G protein-coupled receptor kinase 4","aliases":["G protein-coupled receptor kinase GRK4","ITI1"],"length_aa":578,"mass_kda":66.6,"function":"Specifically phosphorylates the activated forms of G protein-coupled receptors. GRK4-alpha can phosphorylate rhodopsin and its activity is inhibited by calmodulin; the other three isoforms do not phosphorylate rhodopsin and do not interact with calmodulin. GRK4-alpha and GRK4-gamma phosphorylate DRD3. Phosphorylates ADRB2","subcellular_location":"Cytoplasm; Cytoplasm, cell cortex","url":"https://www.uniprot.org/uniprotkb/P32298/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GRK4","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GRK4","total_profiled":1310},"omim":[{"mim_id":"600870","title":"G PROTEIN-COUPLED RECEPTOR KINASE 5; GRK5","url":"https://www.omim.org/entry/600870"},{"mim_id":"137026","title":"G PROTEIN-COUPLED RECEPTOR KINASE 4; GRK4","url":"https://www.omim.org/entry/137026"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"},{"location":"Calyx","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"testis","ntpm":39.6}],"url":"https://www.proteinatlas.org/search/GRK4"},"hgnc":{"alias_symbol":["GPRK4"],"prev_symbol":["GPRK2L"]},"alphafold":{"accession":"P32298","domains":[{"cath_id":"3.30.200.20","chopping":"4-18_182-269_490-504","consensus_level":"high","plddt":93.9003,"start":4,"end":504},{"cath_id":"1.10.167.10","chopping":"40-180","consensus_level":"high","plddt":93.6648,"start":40,"end":180},{"cath_id":"1.10.510.10","chopping":"271-468","consensus_level":"high","plddt":95.8527,"start":271,"end":468}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P32298","model_url":"https://alphafold.ebi.ac.uk/files/AF-P32298-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P32298-F1-predicted_aligned_error_v6.png","plddt_mean":88.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GRK4","jax_strain_url":"https://www.jax.org/strain/search?query=GRK4"},"sequence":{"accession":"P32298","fasta_url":"https://rest.uniprot.org/uniprotkb/P32298.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P32298/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P32298"}},"corpus_meta":[{"pmid":"8626439","id":"PMC_8626439","title":"Characterization of the G protein-coupled receptor kinase GRK4. Identification of four splice variants.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8626439","citation_count":160,"is_preprint":false},{"pmid":"11099476","id":"PMC_11099476","title":"The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1.","date":"2000","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/11099476","citation_count":115,"is_preprint":false},{"pmid":"12881416","id":"PMC_12881416","title":"Phosphorylation-independent desensitization of GABA(B) receptor by GRK4.","date":"2003","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12881416","citation_count":100,"is_preprint":false},{"pmid":"9092566","id":"PMC_9092566","title":"G protein-coupled receptor kinase GRK4. Molecular analysis of the four isoforms and ultrastructural localization in spermatozoa and germinal cells.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9092566","citation_count":80,"is_preprint":false},{"pmid":"17066056","id":"PMC_17066056","title":"Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity.","date":"2006","source":"Nature clinical practice. Nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/17066056","citation_count":73,"is_preprint":false},{"pmid":"10506199","id":"PMC_10506199","title":"The GRK4 subfamily of G protein-coupled receptor kinases. Alternative splicing, gene organization, and sequence conservation.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10506199","citation_count":70,"is_preprint":false},{"pmid":"19520868","id":"PMC_19520868","title":"G protein-coupled receptor kinase 4 (GRK4) regulates the phosphorylation and function of the dopamine D3 receptor.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19520868","citation_count":55,"is_preprint":false},{"pmid":"18413491","id":"PMC_18413491","title":"Blood pressure and renal sodium handling in relation to genetic variation in the DRD1 promoter and GRK4.","date":"2008","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/18413491","citation_count":50,"is_preprint":false},{"pmid":"25770216","id":"PMC_25770216","title":"G Protein-coupled Receptor Kinases of the GRK4 Protein Subfamily Phosphorylate Inactive G Protein-coupled Receptors (GPCRs).","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25770216","citation_count":50,"is_preprint":false},{"pmid":"9607785","id":"PMC_9607785","title":"Rat G protein-coupled receptor kinase GRK4: identification, functional expression, and differential tissue distribution of two splice variants.","date":"1998","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/9607785","citation_count":48,"is_preprint":false},{"pmid":"9495886","id":"PMC_9495886","title":"Sequestration of human muscarinic acetylcholine receptor hm1-hm5 subtypes: effect of G protein-coupled receptor kinases GRK2, GRK4, GRK5 and GRK6.","date":"1998","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/9495886","citation_count":44,"is_preprint":false},{"pmid":"24218433","id":"PMC_24218433","title":"Role of GRK4 in the regulation of arterial AT1 receptor in hypertension.","date":"2013","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/24218433","citation_count":41,"is_preprint":false},{"pmid":"16441255","id":"PMC_16441255","title":"Patterns of genetic variation in the hypertension candidate gene GRK4: ethnic variation and haplotype structure.","date":"2006","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16441255","citation_count":41,"is_preprint":false},{"pmid":"22123211","id":"PMC_22123211","title":"Abnormalities in renal dopamine signaling and hypertension: the role of GRK4.","date":"2012","source":"Current opinion in nephrology and hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/22123211","citation_count":37,"is_preprint":false},{"pmid":"17013811","id":"PMC_17013811","title":"Desensitization of GABA(B) receptor signaling by formation of protein complexes of GABA(B2) subunit with GRK4 or GRK5.","date":"2007","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17013811","citation_count":32,"is_preprint":false},{"pmid":"25775155","id":"PMC_25775155","title":"The importance of G protein-coupled receptor kinase 4 (GRK4) in pathogenesis of salt sensitivity, salt sensitive hypertension and response to antihypertensive treatment.","date":"2015","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25775155","citation_count":25,"is_preprint":false},{"pmid":"22639547","id":"PMC_22639547","title":"Pooled analyses of the associations of polymorphisms in the GRK4 and EMILIN1 genes with hypertension risk.","date":"2012","source":"International journal of medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/22639547","citation_count":21,"is_preprint":false},{"pmid":"26250109","id":"PMC_26250109","title":"The FMRP/GRK4 mRNA interaction uncovers a new mode of binding of the Fragile X mental retardation protein in cerebellum.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/26250109","citation_count":20,"is_preprint":false},{"pmid":"26730182","id":"PMC_26730182","title":"Association between GRK4 and DRD1 gene polymorphisms and hypertension: a meta-analysis.","date":"2015","source":"Clinical interventions in aging","url":"https://pubmed.ncbi.nlm.nih.gov/26730182","citation_count":17,"is_preprint":false},{"pmid":"32940654","id":"PMC_32940654","title":"GRK4-mediated adiponectin receptor-1 phosphorylative desensitization as a novel mechanism of reduced renal sodium excretion in hypertension.","date":"2020","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/32940654","citation_count":17,"is_preprint":false},{"pmid":"35487286","id":"PMC_35487286","title":"Comprehensive insights in GRK4 and hypertension: From mechanisms to potential therapeutics.","date":"2022","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/35487286","citation_count":16,"is_preprint":false},{"pmid":"23509080","id":"PMC_23509080","title":"A novel role for c-Myc in G protein-coupled receptor kinase 4 (GRK4) transcriptional regulation in human kidney proximal tubule cells.","date":"2013","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/23509080","citation_count":13,"is_preprint":false},{"pmid":"33127268","id":"PMC_33127268","title":"Associations of SUCNR1, GRK4, CAMK1D gene polymorphisms and the susceptibility of type 2 diabetes mellitus and essential hypertension in a northern Chinese Han population.","date":"2020","source":"Journal of diabetes and its complications","url":"https://pubmed.ncbi.nlm.nih.gov/33127268","citation_count":12,"is_preprint":false},{"pmid":"32687659","id":"PMC_32687659","title":"Role of GRK4 in the regulation of the renal ETB receptor in hypertension.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32687659","citation_count":10,"is_preprint":false},{"pmid":"36552750","id":"PMC_36552750","title":"LncRNA 148400 Promotes the Apoptosis of Renal Tubular Epithelial Cells in Ischemic AKI by Targeting the miR-10b-3p/GRK4 Axis.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/36552750","citation_count":9,"is_preprint":false},{"pmid":"38365112","id":"PMC_38365112","title":"Exosomal miR-122-3p represses the growth and metastasis of MCF-7/ADR cells by targeting GRK4-mediated activation of the Wnt/β-catenin pathway.","date":"2024","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/38365112","citation_count":7,"is_preprint":false},{"pmid":"15488187","id":"PMC_15488187","title":"Analysis of differential modulatory activities of GRK2 and GRK4 on Galphaq-coupled receptor signaling.","date":"2004","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/15488187","citation_count":7,"is_preprint":false},{"pmid":"37009199","id":"PMC_37009199","title":"Dopamine Receptor D1R and D3R and GRK4 Interaction in Hypertension.","date":"2023","source":"The Yale journal of biology and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37009199","citation_count":6,"is_preprint":false},{"pmid":"37622333","id":"PMC_37622333","title":"Exercise ameliorates skeletal muscle insulin resistance by modulating GRK4-mediated D1R expression.","date":"2023","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/37622333","citation_count":5,"is_preprint":false},{"pmid":"33899625","id":"PMC_33899625","title":"Genetic variants of GRK4 influence circadian rhythm of blood pressure and response to candesartan in hypertensive patients.","date":"2021","source":"Clinical and experimental hypertension (New York, N.Y. : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/33899625","citation_count":5,"is_preprint":false},{"pmid":"37994311","id":"PMC_37994311","title":"GRK4, A Potential Link between Hypertension and Breast Cancer.","date":"2022","source":"Journal of cell science & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37994311","citation_count":3,"is_preprint":false},{"pmid":"34297769","id":"PMC_34297769","title":"Targeted capture sequencing identifies genetic variations of GRK4 and RDH8 in Han Chinese with essential hypertension in Xinjiang.","date":"2021","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/34297769","citation_count":3,"is_preprint":false},{"pmid":"37641972","id":"PMC_37641972","title":"Effect of GRK4 on renal gastrin receptor regulation in hypertension.","date":"2023","source":"Clinical and experimental hypertension (New York, N.Y. : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/37641972","citation_count":2,"is_preprint":false},{"pmid":"40484036","id":"PMC_40484036","title":"Inhibition of GRK4 reduces arrhythmia susceptibility and alleviates connexin43 dysregulation after myocardial infarction.","date":"2025","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40484036","citation_count":1,"is_preprint":false},{"pmid":"39558015","id":"PMC_39558015","title":"A cross-tissue transcriptome-wide association study reveals GRK4 as a novel susceptibility gene for COPD.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39558015","citation_count":1,"is_preprint":false},{"pmid":"38471134","id":"PMC_38471134","title":"Chronic exercise improves renal AT1 and ETB receptor functions via modulating GRK4 expression in obese Zucker rats.","date":"2024","source":"Clinical and experimental hypertension (New York, N.Y. : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/38471134","citation_count":1,"is_preprint":false},{"pmid":"41407053","id":"PMC_41407053","title":"GRK4 R65L causes salt-sensitive hypertension by augmenting renal Hao2-mediated oxidative stress via increasing the phosphorylation of TPI1 and promoting H3K27ac expression.","date":"2025","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41407053","citation_count":0,"is_preprint":false},{"pmid":"41351606","id":"PMC_41351606","title":"PM2.5-induced hypertension via renal GRK4/Nedd4L/ENaC axis: epigenetic and post-translational mechanisms.","date":"2025","source":"Blood pressure","url":"https://pubmed.ncbi.nlm.nih.gov/41351606","citation_count":0,"is_preprint":false},{"pmid":"41161545","id":"PMC_41161545","title":"Omentin-1 attenuates salt-sensitive hypertension via GRK4/AT1R downregulation mediated by the ROS/c-Myc pathway.","date":"2025","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41161545","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":22627,"output_tokens":5622,"usd":0.076106},"stage2":{"model":"claude-opus-4-6","input_tokens":9285,"output_tokens":3596,"usd":0.204487},"total_usd":0.280593,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"GRK4 is a functional protein kinase capable of phosphorylating agonist-occupied purified β2-adrenergic receptor in vitro, augmenting desensitization of the rat LH/CG receptor upon coexpression in HEK293 cells, and all four splice variants incorporate [3H]palmitate (palmitoylation).\",\n      \"method\": \"In vitro phosphorylation assay with purified β2-adrenergic receptor; coexpression desensitization assay in HEK293 cells; [3H]palmitate metabolic labeling\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay plus functional cell-based desensitization, foundational paper with 160 citations\",\n      \"pmids\": [\"8626439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"GRK4α, but not the β, γ, or δ isoforms, phosphorylates rhodopsin in an agonist-dependent manner; GRK4α kinase activity is inhibited by Ca²⁺/calmodulin (IC50 ~80 nM) through direct interaction, while the other isoforms do not interact with calmodulin. GRK4 protein localizes to acrosomal and outer mitochondrial membranes of human spermatozoa, with GRK4γ being the only detectable isoform in sperm.\",\n      \"method\": \"Rhodopsin phosphorylation assay; CaM-Sepharose pulldown; immunochemistry and ultrastructural (EM) localization in sperm\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with isoform-specific comparisons plus direct binding pulldown and subcellular localization by EM\",\n      \"pmids\": [\"9092566\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Rat GRK4A and GRK4B are both functional protein kinases demonstrated by rhodopsin phosphorylation; GRK4A mRNA is enriched in testicular spermatocytes/spermatids whereas GRK4B is enriched ~20-fold in renal outer medulla, indicating isoform-specific tissue distribution with distinct physiological functions.\",\n      \"method\": \"Rhodopsin phosphorylation assay; in situ hybridization; quantitative RT-PCR\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay combined with two independent localization methods\",\n      \"pmids\": [\"9607785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"GRK4δ facilitates sequestration of muscarinic m2 (and to a lesser extent m4) receptors in BHK-21 cells but not in COS-7 cells, indicating cell-type-dependent modulation of muscarinic receptor internalization.\",\n      \"method\": \"Receptor sequestration assay (loss of [3H]NMS surface binding) with GRK4δ coexpression in COS-7 and BHK-21 cells\",\n      \"journal\": \"The Journal of pharmacology and experimental therapeutics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single coexpression assay, moderate mechanistic follow-up\",\n      \"pmids\": [\"9495886\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"GRK4 mediates homologous desensitization of the metabotropic glutamate receptor mGlu1 in cerebellar Purkinje cells: GRK4 coexpression in HEK293 cells caused agonist-dependent mGlu1 desensitization, agonist stimulation induced GRK4 redistribution and colocalization with internalized receptor, kinase activity was required, and agonist-dependent phosphorylation of mGlu1 was demonstrated. Antisense reduction of GRK4 in Purkinje cells impaired mGlu1 desensitization.\",\n      \"method\": \"Coexpression desensitization assay in HEK293; receptor phosphorylation assay; confocal colocalization; antisense knockdown in cultured Purkinje cells\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (phosphorylation, localization, antisense KD) in both heterologous and native cells, 115 citations\",\n      \"pmids\": [\"11099476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"GRK4 mediates agonist-promoted desensitization of the heterodimeric GABA(B) receptor in cerebellar granule cells through a phosphorylation-independent mechanism: GRK4 kinase-domain deletion mutants still promoted desensitization, siRNA knockdown of GRK4 in granule cells blocked desensitization, and GRK4 transfection into HEK293 cells reconstituted desensitization without detectable ligand-induced receptor phosphorylation.\",\n      \"method\": \"siRNA knockdown in cerebellar granule cells; kinase-dead/deletion mutant transfection; electrophysiological desensitization assay in HEK293 cells\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — loss-of-function siRNA plus domain-deletion mutagenesis with defined phenotypic readout, 100 citations\",\n      \"pmids\": [\"12881416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Unlike GRK2, the N-terminal RGS-like domain of GRK4 does not interact with Gαq either in vitro or in cells and cannot inhibit Gαq-dependent signaling, establishing that GRK4 lacks functional Gαq interaction.\",\n      \"method\": \"In vitro Gαq binding assay; cell-based signaling assay comparing GRK2 and GRK4 N-terminal domains\",\n      \"journal\": \"Methods in enzymology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding assay in vitro and in cells, but single lab\",\n      \"pmids\": [\"15488187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GRK4 desensitizes GABA(B) receptor by forming a direct protein complex with the GB2 subunit: agonist stimulation translocated cytosolic GRK4 to the plasma membrane, and FRET analysis (GRK4-Cerulean/GB2R-Venus) plus co-immunoprecipitation confirmed a physical GRK4–GB2R complex. GRK5 also formed this complex but GRK2, GRK3, and GRK6 did not.\",\n      \"method\": \"FRET (fluorescent fusion proteins); co-immunoprecipitation; live-cell translocation imaging in BHK cells; Xenopus oocyte electrophysiology\",\n      \"journal\": \"Journal of cellular physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — FRET plus co-IP plus functional electrophysiology, orthogonal methods in single study\",\n      \"pmids\": [\"17013811\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GRK4 (specifically GRK4γ and GRK4α isoforms) directly interacts with and phosphorylates the agonist-activated dopamine D3 receptor: bimolecular fluorescence complementation showed agonist-dependent GRK4–D3R interaction at the membrane and intracellularly; GRK4γ and α isoforms caused 3- and 2-fold increases in D3R phosphorylation, respectively; GRK4 knockdown abolished D3R-mediated p44/42 phosphorylation and mitogenesis.\",\n      \"method\": \"Bimolecular fluorescence complementation (BiFC); co-immunoprecipitation; receptor phosphorylation assay; RNAi knockdown with signaling readout in human proximal tubule cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (BiFC, co-IP, phosphorylation, KD) with defined functional readout\",\n      \"pmids\": [\"19520868\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GRK4γ directly interacts with angiotensin II type 1 receptor (AT1R); the gain-of-function variant GRK4γ 142V increases AT1R protein expression via NF-κB-mediated transcriptional upregulation, decreases AT1R phosphorylation (reducing degradation), and augments AT1R-mediated calcium signaling. The interaction between GRK4γ and AT1R is decreased by the 142V variant.\",\n      \"method\": \"Co-immunoprecipitation; NF-κB luciferase reporter; chromatin immunoprecipitation; calcium imaging; GRK4γ 142V transgenic mice with aortic vasoconstriction assay\",\n      \"journal\": \"Hypertension\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in cells plus in vivo transgenic confirmation\",\n      \"pmids\": [\"24218433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"c-Myc transcription factor binds to the GRK4 promoter and positively regulates GRK4 expression in human renal proximal tubule cells; angiotensin II (via AT1R) activates c-Myc phosphorylation, which in turn increases GRK4 expression and causes dopamine D1 receptor uncoupling from adenylyl cyclase.\",\n      \"method\": \"Chromatin immunoprecipitation; c-Myc inhibitor (10074-G5); AT1R blockade with losartan; adenylyl cyclase coupling assay\",\n      \"journal\": \"Hypertension\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus pharmacological inhibition at multiple nodes, defining the Ang II→AT1R→c-Myc→GRK4→D1R axis\",\n      \"pmids\": [\"23509080\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FMRP (fragile X mental retardation protein) binds directly to a structured domain (G4RIF) in GRK4 mRNA via its C-terminal region, repressing GRK4 translation in cerebellar Purkinje cells; in Fmr1-null cerebellum, GRK4 protein is increased without change in mRNA, indicating translational repression by FMRP.\",\n      \"method\": \"In vitro FMRP–mRNA binding assay; RNA secondary structure analysis; Western blot and qRT-PCR in Fmr1-null cerebellum; reporter translational repression assay\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro binding plus structural characterization plus in vivo genetic model with translational readout\",\n      \"pmids\": [\"26250109\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GRK4 subfamily members (GRK5 and GRK6, but not GRK2/3) phosphorylate inactive (non-agonist-occupied) GPCRs including β2-adrenergic and M2 muscarinic receptors; this agonist-independent phosphorylation enhances arrestin recruitment to inactive receptors, and arrestin-3 discriminates between GRK2- and GRK5-mediated phosphorylation patterns.\",\n      \"method\": \"In vitro phosphorylation assay with inactive receptors; arrestin recruitment assay; constitutive activity controls; membrane association controls\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with rigorous controls distinguishing GRK subfamilies\",\n      \"pmids\": [\"25770216\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GRK4 directly interacts with and hyperphosphorylates the adiponectin receptor-1 (AdipoR1) in renal proximal tubule cells from spontaneously hypertensive rats (SHRs), uncoupling AdipoR1 from Gαi and impairing adiponectin-mediated inhibition of Na⁺-K⁺-ATPase; GRK4γ 142V transgenic mice replicate this phenotype, and siRNA-mediated GRK4 knockdown in vivo restores adiponectin-induced natriuresis and reduces blood pressure.\",\n      \"method\": \"Co-immunoprecipitation; point mutation abolishing receptor phosphorylation; GRK4γ 142V transgenic mice; renal siRNA knockdown via ultrasound-targeted microbubble destruction; Na⁺-K⁺-ATPase activity assay\",\n      \"journal\": \"Clinical science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP, mutagenesis rescue, transgenic and knockdown in vivo with defined physiological readout\",\n      \"pmids\": [\"32940654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GRK4 co-localizes and co-immunoprecipitates with the endothelin ETB receptor in renal proximal tubule cells; in SHRs and GRK4γ 142V transgenic mice, ETBR is hyperphosphorylated by GRK4, impairing ETBR-mediated natriuresis and diuresis; siRNA knockdown or in vivo GRK4 reduction restores ETBR function.\",\n      \"method\": \"Co-immunoprecipitation; confocal colocalization; GRK4γ 142V transgenic mice; siRNA knockdown via ultrasound-targeted microbubble destruction; in vivo natriuresis assay\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — co-IP plus transgenic and knockdown in vivo with functional natriuresis readout\",\n      \"pmids\": [\"32687659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GRK4 phosphorylates the cholecystokinin B receptor (CCKBR/gastrin receptor) in renal proximal tubule cells; GRK4 and CCKBR co-localize and co-immunoprecipitate; GRK4 siRNA reduces CCKBR phosphorylation and restores gastrin-mediated inhibition of Na⁺-K⁺-ATPase activity in SHR cells.\",\n      \"method\": \"Co-immunoprecipitation; confocal co-localization; siRNA knockdown; Na⁺-K⁺-ATPase activity assay; GRK4 A142V transgenic mice\",\n      \"journal\": \"Clinical and experimental hypertension\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP plus functional enzyme assay and KD, single lab\",\n      \"pmids\": [\"37641972\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GRK4-mediated phosphorylation of dopamine D1R in skeletal muscle is regulated upstream by a ROS/c-Myc pathway: in insulin-resistant/T2DM mice, increased ROS elevates c-Myc expression, which transcriptionally upregulates GRK4, leading to D1R hyperphosphorylation and impaired insulin sensitivity; exercise reverses this axis, and GRK4 transgenic mice show worsened D1R phosphorylation and insulin resistance while AAV9-shGRK4 mice are more insulin sensitive.\",\n      \"method\": \"GRK4 transgenic and AAV9-shGRK4 mice; glucose and insulin tolerance tests; D1R phosphorylation assay; c-Myc ChIP; ROS measurement\",\n      \"journal\": \"Clinical science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — gain- and loss-of-function in vivo with defined molecular and physiological readouts\",\n      \"pmids\": [\"37622333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GRK4 promotes arrhythmia after myocardial infarction by binding to and phosphorylating the M3 muscarinic acetylcholine receptor (M3-mAChR), which impedes M3-mAChR–Cx43 association, causing Cx43 downregulation and redistribution; GRK4 mRNA/protein stability is increased via METTL3-mediated m6A modification read by YTHDF1. GRK4 knockdown reduces Cx43 dysregulation and ventricular arrhythmia susceptibility.\",\n      \"method\": \"siRNA and adenoviral overexpression of GRK4 in cardiomyocytes; co-immunoprecipitation (GRK4–M3-mAChR; M3-mAChR–Cx43); m6A RNA methylation assay; METTL3/YTHDF1 interaction; in vivo arrhythmia susceptibility assay post-MI\",\n      \"journal\": \"Biochemical pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP plus KD/OE with defined arrhythmia and molecular readouts, single lab\",\n      \"pmids\": [\"40484036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GRK4 R65L variant causes salt-sensitive hypertension via phosphorylation of triosephosphate isomerase 1 (TPI1), which promotes TPI1 nuclear translocation, reduces DHAP levels, increases H3K27ac binding to the Hao2 promoter, and upregulates Hao2-mediated renal oxidative stress. Immunoprecipitation-mass spectrometry identified increased GRK4–TPI1 interaction in kidneys of high-salt-fed GRK4 R65L mice.\",\n      \"method\": \"GRK4 R65L global and renal-targeted transgenic mice; immunoprecipitation–mass spectrometry; TPI1 phosphorylation and nuclear fractionation; H3K27ac ChIP; Hao2 AAV9 knockdown; oxidative stress measurement; pressure-natriuresis assay\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — IP-MS identification plus multiple in vivo genetic manipulations, single lab, 0 citations (very recent)\",\n      \"pmids\": [\"41407053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"PM2.5 upregulates renal GRK4 expression via promoter hypomethylation; elevated GRK4 then phosphorylates and interacts with Nedd4L (a ubiquitin ligase), stabilizing Nedd4L phosphorylation; phospho-Nedd4L reduces ENaC ubiquitination, causing ENaC accumulation and sodium retention that drives hypertension. GRK4 overexpression exacerbated and knockdown attenuated these effects.\",\n      \"method\": \"Co-immunoprecipitation (GRK4–Nedd4L); methylation assay; lentiviral GRK4 overexpression/knockdown; ENaC ubiquitination assay; Western blot; in vivo blood pressure measurement\",\n      \"journal\": \"Blood pressure\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-IP plus lentiviral gain/loss-of-function with defined sodium channel readout, single lab, very recent\",\n      \"pmids\": [\"41351606\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GRK4 is a palmitoylated, constitutively active serine/threonine kinase (expressed highly in testis and renal proximal tubule) that phosphorylates and desensitizes multiple GPCRs—including dopamine D1R, D3R, mGlu1, LH/CG receptor, ETBR, CCKBR, and M3-mAChR—as well as non-GPCR substrates such as adiponectin receptor-1 and TPI1, with its activity regulated by isoform-specific calmodulin inhibition and transcriptionally controlled by the Ang II→AT1R→c-Myc axis; gain-of-function variants (R65L, A142V, A486V) cause constitutive receptor hyperphosphorylation that impairs renal natriuresis and elevates blood pressure, while in the cerebellum FMRP restrains GRK4 translation to control GABA(B) receptor desensitization.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GRK4 is a palmitoylated serine/threonine kinase of the GRK4 subfamily that phosphorylates and desensitizes a broad repertoire of G protein-coupled receptors—including dopamine D1R and D3R, mGlu1, GABA(B), LH/CG, ETB, CCKB, and M3-mAChR—as well as non-GPCR substrates such as adiponectin receptor-1, TPI1, and Nedd4L, thereby governing renal sodium handling, vascular tone, insulin sensitivity, and cardiac gap-junction integrity [PMID:8626439, PMID:11099476, PMID:19520868, PMID:32940654, PMID:41407053, PMID:40484036]. The kinase exists as four splice isoforms whose activity is differentially regulated by Ca²⁺/calmodulin (which inhibits GRK4α but not β/γ/δ) and whose expression is transcriptionally driven by an angiotensin II→AT1R→c-Myc axis, while post-transcriptionally FMRP represses GRK4 translation in cerebellum and METTL3-mediated m⁶A modification stabilizes GRK4 mRNA in cardiomyocytes [PMID:9092566, PMID:23509080, PMID:26250109, PMID:40484036]. Gain-of-function variants (R65L, A142V, A486V) confer constitutive receptor hyperphosphorylation in renal proximal tubule cells, impairing natriuresis and causing salt-sensitive hypertension in transgenic models [PMID:24218433, PMID:32687659, PMID:41407053]. GRK4 can also desensitize GABA(B) receptors through a phosphorylation-independent mechanism that involves direct binding to the GB2 subunit [PMID:12881416, PMID:17013811].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing GRK4 as a functional GPCR kinase resolved whether this testis-enriched gene encodes an active enzyme: all four splice variants phosphorylated agonist-occupied β2-adrenergic receptor, desensitized LH/CG receptor, and incorporated palmitate, placing GRK4 in the GRK family with a membrane-anchoring mechanism.\",\n      \"evidence\": \"In vitro kinase assay with purified β2AR; HEK293 coexpression desensitization; [³H]palmitate labeling\",\n      \"pmids\": [\"8626439\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous substrates in testis not identified\", \"Palmitoylation site(s) not mapped\", \"Contribution to spermatogenesis unknown\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrating that Ca²⁺/calmodulin selectively inhibits GRK4α (IC₅₀ ~80 nM) but not the other isoforms revealed an isoform-specific regulatory mechanism, while EM localization to sperm acrosomes and mitochondria defined the first subcellular address for endogenous GRK4.\",\n      \"evidence\": \"Rhodopsin phosphorylation with CaM titration; CaM-Sepharose pulldown; immunoEM of human spermatozoa\",\n      \"pmids\": [\"9092566\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Calmodulin-binding site on GRK4α not mapped\", \"Functional consequence of CaM regulation in spermatozoa not tested\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identifying mGlu1 as an endogenous GRK4 substrate in cerebellar Purkinje cells established GRK4 as a physiologically relevant kinase outside of testis, with antisense knockdown confirming a non-redundant role in mGlu1 desensitization.\",\n      \"evidence\": \"HEK293 desensitization/phosphorylation assays; confocal colocalization; antisense oligonucleotide knockdown in cultured Purkinje cells\",\n      \"pmids\": [\"11099476\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation sites on mGlu1 not mapped\", \"In vivo cerebellar phenotype of GRK4 loss not examined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showing that GRK4 desensitizes GABA(B) receptor through a phosphorylation-independent mechanism expanded the paradigm beyond kinase activity, indicating GRK4 can function as a scaffolding partner for receptor regulation.\",\n      \"evidence\": \"Kinase-dead/deletion mutants retain desensitization; siRNA knockdown in cerebellar granule cells; HEK293 electrophysiology\",\n      \"pmids\": [\"12881416\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of phosphorylation-independent desensitization (e.g., arrestin recruitment) not defined\", \"Which GRK4 domain mediates the scaffolding function unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"FRET and co-IP identification of a direct GRK4–GB2 subunit complex provided the physical basis for GABA(B) receptor desensitization and showed specificity within the GRK family (GRK2/3/6 did not form this complex).\",\n      \"evidence\": \"FRET (Cerulean/Venus fusions); co-immunoprecipitation; translocation imaging in BHK cells; Xenopus oocyte electrophysiology\",\n      \"pmids\": [\"17013811\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GB2 binding interface on GRK4 not mapped\", \"Whether GB2 interaction is phosphorylation-dependent or -independent not resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrating that GRK4γ and GRK4α phosphorylate dopamine D3R in renal proximal tubule cells, with knockdown abolishing D3R-mediated ERK signaling, linked GRK4 to renal dopaminergic signaling and natriuretic regulation.\",\n      \"evidence\": \"BiFC; co-IP; receptor phosphorylation assay; RNAi in human renal proximal tubule cells\",\n      \"pmids\": [\"19520868\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"D3R phosphorylation sites by GRK4 not mapped\", \"In vivo renal D3R desensitization phenotype not tested\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Two parallel studies revealed that GRK4 expression is transcriptionally controlled by angiotensin II→AT1R→c-Myc signaling, and that the gain-of-function GRK4γ 142V variant reciprocally upregulates AT1R via NF-κB, establishing a positive feedback loop in hypertension pathogenesis.\",\n      \"evidence\": \"ChIP for c-Myc on GRK4 promoter; c-Myc inhibitor; losartan; NF-κB reporter; GRK4γ 142V transgenic mice with vasoconstriction and calcium assays\",\n      \"pmids\": [\"23509080\", \"24218433\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of c-Myc versus other transcription factors not quantified\", \"Whether AT1R upregulation by 142V occurs in human kidneys not confirmed\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Discovery that FMRP directly binds a G4RIF structural element in GRK4 mRNA and represses its translation connected GRK4 to fragile X syndrome biology and explained elevated GRK4 protein in Fmr1-null cerebellum.\",\n      \"evidence\": \"In vitro FMRP–RNA binding; RNA structure analysis; Fmr1-KO mouse cerebellum Western/qRT-PCR; reporter translation assay\",\n      \"pmids\": [\"26250109\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether elevated GRK4 protein causes specific GABA(B) or mGlu1 dysfunction in Fmr1-KO not tested\", \"Other translational regulators of GRK4 not examined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Extending GRK4 substrates beyond GPCRs, two studies showed that GRK4 hyperphosphorylates adiponectin receptor-1 and endothelin ETB receptor in hypertensive rat kidneys, with in vivo GRK4 siRNA restoring natriuresis and lowering blood pressure, establishing GRK4 as a master desensitizer of multiple renal antinatriuretic pathways.\",\n      \"evidence\": \"Co-IP; GRK4γ 142V transgenic mice; renal-targeted siRNA via ultrasound microbubble destruction; Na⁺-K⁺-ATPase activity; natriuresis assays\",\n      \"pmids\": [\"32940654\", \"32687659\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation sites on AdipoR1 and ETBR not mapped\", \"Whether GRK4 simultaneously targets all these receptors in the same cell not determined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of CCKBR as another GRK4 renal substrate and demonstration that a ROS/c-Myc/GRK4 axis impairs D1R-mediated insulin sensitivity in skeletal muscle broadened GRK4 function to metabolic regulation beyond kidney.\",\n      \"evidence\": \"Co-IP (GRK4–CCKBR); GRK4 transgenic and AAV9-shGRK4 mice; glucose/insulin tolerance tests; c-Myc ChIP in skeletal muscle\",\n      \"pmids\": [\"37641972\", \"37622333\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GRK4 directly phosphorylates CCKBR intracellular domains not confirmed with site mutagenesis\", \"Skeletal muscle-specific GRK4 knockout not performed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Three recent studies expanded the GRK4 substrate repertoire to non-receptor targets: GRK4 phosphorylates TPI1 (promoting its nuclear translocation and epigenetic upregulation of Hao2 in salt-sensitive hypertension), binds M3-mAChR to disrupt Cx43-mediated gap junctions and promote post-MI arrhythmia (with GRK4 stability itself controlled by METTL3/m⁶A/YTHDF1), and phosphorylates Nedd4L to stabilize ENaC and cause sodium retention under PM2.5 exposure.\",\n      \"evidence\": \"IP-MS (GRK4–TPI1); GRK4 R65L transgenic mice; H3K27ac ChIP; co-IP (GRK4–M3-mAChR, GRK4–Nedd4L); m⁶A-RIP; in vivo arrhythmia and blood pressure assays\",\n      \"pmids\": [\"41407053\", \"40484036\", \"41351606\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"TPI1 phosphorylation site(s) and direct kinase assay not reported\", \"M3-mAChR and Nedd4L findings each from a single lab, awaiting independent replication\", \"Structural basis for GRK4 recognition of non-GPCR substrates entirely unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis for GRK4's broad substrate promiscuity across GPCRs and non-GPCR targets, the phosphorylation-independent desensitization mechanism for GABA(B) receptor, identification of phosphorylation sites on most reported substrates, and whether a GRK4 knockout mouse recapitulates the predicted hypotensive/salt-resistant phenotype.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal structure of GRK4 or GRK4–substrate complex\", \"Full GRK4 knockout mouse phenotype not reported in the literature\", \"Phosphorylation sites mapped on very few substrates\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 1, 4, 8, 13, 14, 15, 18]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 7, 8, 9]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 4, 5, 8, 9, 10, 13, 14, 15, 16]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [13, 14, 19]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [4, 5, 7, 11]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"DRD1\",\n      \"DRD3\",\n      \"GRM1\",\n      \"GABBR2\",\n      \"ADIPOR1\",\n      \"EDNRB\",\n      \"AGTR1\",\n      \"TPI1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}